These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12422304)

  • 41. Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
    Nishimura J; Satoh T; Fukunaga M; Takemoto H; Nakata K; Ide Y; Fukuzaki T; Kudo T; Miyake Y; Yasui M; Morita S; Sakai D; Uemura M; Hata T; Takemasa I; Mizushima T; Ohno Y; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M;
    Eur J Cancer; 2015 Jul; 51(10):1274-82. PubMed ID: 25922233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis.
    Wen F; Zhou Y; Wang W; Hu QC; Liu YT; Zhang PF; Du ZD; Dai J; Li Q
    Ann Oncol; 2013 Jan; 24(1):171-8. PubMed ID: 22898039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxaliplatin-induced acute thrombocytopenia.
    Erdem GU; Dogan M; Demirci NS; Zengin N
    J Cancer Res Ther; 2016; 12(2):509-14. PubMed ID: 27461601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Survey of oxaliplatin-associated peripheral sensory neuropathy using an interview-based questionnaire in patients with advanced colorectal cancer].
    Satomi M; Kono T; Mamiya N; Chisato N; Ebisawa Y; Sugawara M; Saito T; Matsubara K; Kasai S
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1321-5. PubMed ID: 19692771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.
    Gamelin E; Gamelin L; Bossi L; Quasthoff S
    Semin Oncol; 2002 Oct; 29(5 Suppl 15):21-33. PubMed ID: 12422305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.
    Besora S; Santos C; Izquierdo C; Martinez-Villacampa MM; Bruna J; Velasco R
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1793-1801. PubMed ID: 29955956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
    Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
    J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.
    Lee MY; Yang MH; Liu JH; Yen CC; Lin PC; Teng HW; Wang WS; Chiou TJ; Chen PM
    Support Care Cancer; 2007 Jan; 15(1):89-93. PubMed ID: 16865410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxaliplatin-related thrombocytopenia.
    Jardim DL; Rodrigues CA; Novis YAS; Rocha VG; Hoff PM
    Ann Oncol; 2012 Aug; 23(8):1937-1942. PubMed ID: 22534771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
    Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
    World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital ischaemia and necrosis from oxaliplatin.
    Huang C; Storey L; Chaudhary U
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35131793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I study of oxaliplatin in patients with advanced cancer.
    Extra JM; Espie M; Calvo F; Ferme C; Mignot L; Marty M
    Cancer Chemother Pharmacol; 1990; 25(4):299-303. PubMed ID: 2295116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.
    Pietrantonio F; Di Bartolomeo M; Buzzoni R; Bajetta E
    Tumori; 2010; 96(1):154-6. PubMed ID: 20437874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.
    Han CH; Kilfoyle DH; Hill AG; Jameson MB; McKeage MJ
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1479-1490. PubMed ID: 27539508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oxaliplatin-associated neurotoxicity in clinical practice].
    Mas Morey P; Cholvi Llovell M; Nigorra Caro M; Nicolás Picó J; Vilanova Boltó M
    Farm Hosp; 2012; 36(5):336-42. PubMed ID: 22118767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of preliminary medication on oxaliplatin hypersensitivity].
    Sato J; Terui K; Hayakari M
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1125-9. PubMed ID: 19620801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
    Khattak MA
    Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
    Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
    J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The side effects of platinum-based chemotherapy drugs: a review for chemists.
    Oun R; Moussa YE; Wheate NJ
    Dalton Trans; 2018 May; 47(19):6645-6653. PubMed ID: 29632935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.